Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
Alessandro Vitale, Gianluca Svegliati‐Baroni, Alessio Ortolani, et al.
Gut (2021) Vol. 72, Iss. 1, pp. 141-152
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Changing epidemiology, global trends and implications for outcomes of NAFLD
Vincent Wai‐Sun Wong, Mattias Ekstedt, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 842-852
Open Access | Times Cited: 268
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
Giovanni Targher, Christopher D. Byrne, Herbert Tilg
Gut (2024), pp. gutjnl-330595
Open Access | Times Cited: 212
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxı̀
Viruses (2022) Vol. 14, Iss. 5, pp. 986-986
Open Access | Times Cited: 105
MAFLD: a multisystem disease
Rosaria Maria Pipitone, Carlo Ciccioli, Giuseppe Infantino, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 96
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 797-809
Closed Access | Times Cited: 82
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 883-883
Open Access | Times Cited: 58
The first MASH drug therapy on the horizon: Current perspectives of resmetirom
Salvatore Petta, Giovanni Targher, Stefano Romeo, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1526-1536
Open Access | Times Cited: 56
Epidemiology of Metabolic Dysfunction Associated Steatotic Liver Disease
Zobair M. Younossi, Markos Kalligeros, Linda Henry
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 26
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal
Franco Trevisani, Alessandro Vitale, Masatoshi Kudo, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 661-669
Closed Access | Times Cited: 24
Inequities in primary liver cancer in Europe: The state of play
Loreta A. Kondili, Jeffrey V. Lazarus, Peter Jepsen, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 645-660
Open Access | Times Cited: 17
"Evolving epidemiology of HCC in Spain"
Margarita Sala, Sonia Pascual, Montserrat Roca, et al.
JHEP Reports (2025), pp. 101336-101336
Open Access | Times Cited: 2
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
Grazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 195-211
Open Access | Times Cited: 32
Role of ammonia in NAFLD: An unusual suspect
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein Kerbert, et al.
JHEP Reports (2023) Vol. 5, Iss. 7, pp. 100780-100780
Open Access | Times Cited: 23
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma
Maria Effenberger, Silvio Waschina, Christina Bronowski, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 22
MAFLD: an optimal framework for understanding liver cancer phenotypes
Harry Crane, Cameron Gofton, Ankur Sharma, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 10, pp. 947-964
Open Access | Times Cited: 22
A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma
Tommaso Stroffolini, Giacomo Stroffolini
Cancers (2023) Vol. 15, Iss. 8, pp. 2388-2388
Open Access | Times Cited: 19
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do
Walaa Abdelhamed, Mohamed El‐Kassas
Liver Research (2024) Vol. 8, Iss. 2, pp. 83-90
Open Access | Times Cited: 6
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
Maria Eva Argenziano, Mi Na Kim, Michele Montori, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 922-940
Closed Access | Times Cited: 6
Application of intelligent tongue image analysis in Conjunction with microbiomes in the diagnosis of MAFLD
Shixuan Dai, Xiaojing Guo, Shi Liu, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29269-e29269
Open Access | Times Cited: 5
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study
Shen Di, Xintian Cai, Junli Hu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
The Spectrum and Outcome of Metastatic Hepatocellular Carcinoma in a South African Patient Cohort
Muhammad Emmamally, U. Kotze, M. Bernon, et al.
HPB (2025)
Closed Access
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma
Edoardo G. Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access
Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis
Andrea Pasta, Antonio Facciorusso, Maria Corina Plaz Torres, et al.
European Journal of Clinical Investigation (2025)
Open Access
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access
Changing epidemiology of hepatocellular carcinoma in the Mediterranean area: a challenge for surveillance?
Andrea Pasta, Giulia Pieri, Edoardo G. Giannini
JHEP Reports (2025), pp. 101396-101396
Closed Access
Page 1 - Next Page

Scroll to top